David Arterburn to Gastric Bypass
This is a "connection" page, showing publications David Arterburn has written about Gastric Bypass.
Connection Strength
7.647
-
Comparing the Outcomes of Sleeve Gastrectomy and Roux-en-Y Gastric Bypass for Severe Obesity. JAMA. 2018 01 16; 319(3):235-237.
Score: 0.565
-
Bariatric Surgery for Type 2 Diabetes: Getting Closer to the Long-term Goal. JAMA. 2016 Mar 22-29; 315(12):1276-7.
Score: 0.496
-
Comparative effectiveness of laparoscopic adjustable gastric banding vs laparoscopic gastric bypass. JAMA Surg. 2014 Dec; 149(12):1279-87.
Score: 0.455
-
Predicting 90-day mortality after bariatric surgery: an independent, external validation of the OS-MRS prognostic risk score. Surg Obes Relat Dis. 2014 Sep-Oct; 10(5):774-9.
Score: 0.435
-
Gastric bypass surgery is more efficacious than intensive lifestyle and medical treatment for type 2 diabetes remission. Evid Based Med. 2014 Apr; 19(2):e14.
Score: 0.424
-
The authors respond: a multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg. 2013 Sep; 23(9):1456-7.
Score: 0.417
-
Predictors of initial weight loss after gastric bypass surgery in twelve Veterans Affairs Medical Centers. Obes Res Clin Pract. 2013 Sep-Oct; 7(5):e367-76.
Score: 0.417
-
A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg. 2013 Jan; 23(1):93-102.
Score: 0.398
-
Change in predicted 10-year cardiovascular risk following laparoscopic Roux-en-Y gastric bypass surgery. Obes Surg. 2009 Feb; 19(2):184-189.
Score: 0.294
-
Comparative Safety and Effectiveness of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy for Weight Loss and Type 2 Diabetes Across Race and Ethnicity in the PCORnet Bariatric Study Cohort. JAMA Surg. 2022 10 01; 157(10):897-906.
Score: 0.196
-
Remission and Relapse of Dyslipidemia After Vertical Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass in a Racially and Ethnically Diverse Population. JAMA Netw Open. 2022 09 01; 5(9):e2233843.
Score: 0.195
-
Association of Insurance Coverage With Adoption of Sleeve Gastrectomy vs Gastric Bypass for Patients Undergoing Bariatric Surgery. JAMA Netw Open. 2022 08 01; 5(8):e2225964.
Score: 0.193
-
The Effect of Bariatric Surgery on Long-term Depression Treatment in Patients With Obesity. Ann Surg. 2022 08 01; 276(2):318-323.
Score: 0.192
-
Comparison of Ambulatory Health Care Costs and Use Associated With Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy. JAMA Netw Open. 2022 05 02; 5(5):e229661.
Score: 0.190
-
Comparative effectiveness of gastric bypass and sleeve gastrectomy on predicted 10-year risk of cardiovascular disease 5 years after surgery. Surg Obes Relat Dis. 2022 06; 18(6):716-726.
Score: 0.188
-
Comparative Safety of Sleeve Gastrectomy and Gastric Bypass Up to 5 Years After Surgery in Patients With Severe Obesity. JAMA Surg. 2021 12 01; 156(12):1160-1169.
Score: 0.185
-
Comparative Effectiveness of Vertical Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass for Diabetes Treatment: A Claims-based Cohort Study. Ann Surg. 2021 05 01; 273(5):940-948.
Score: 0.177
-
Interventions and Operations after Bariatric Surgery in a Health Plan Research Network Cohort from the PCORnet, the National Patient-Centered Clinical Research Network. Obes Surg. 2021 08; 31(8):3531-3540.
Score: 0.177
-
Five-year Longitudinal Cohort Study of Reinterventions After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass. Ann Surg. 2021 04 01; 273(4):758-765.
Score: 0.176
-
Bariatric Surgical Alterations in Tolerability, Enjoyment and Cravings in the Diet (BSATED) instrument: A new scale to measure food preferences following bariatric surgery. Appetite. 2021 07 01; 162:105151.
Score: 0.174
-
Concurrent hiatal hernia repair and bariatric surgery: outcomes after sleeve gastrectomy and Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2021 Jan; 17(1):72-80.
Score: 0.169
-
Long-term opioid use after bariatric surgery. Surg Obes Relat Dis. 2020 Aug; 16(8):1100-1110.
Score: 0.166
-
Comparing the 5-Year Diabetes Outcomes of Sleeve Gastrectomy and Gastric Bypass: The National Patient-Centered Clinical Research Network (PCORNet) Bariatric Study. JAMA Surg. 2020 05 01; 155(5):e200087.
Score: 0.165
-
Interventions and Operations 5 Years After Bariatric Surgery in a Cohort From the US National Patient-Centered Clinical Research Network Bariatric Study. JAMA Surg. 2020 03 01; 155(3):194-204.
Score: 0.164
-
Risk of Operative and Nonoperative Interventions Up to 4 Years After Roux-en-Y Gastric Bypass vs Vertical Sleeve Gastrectomy in a Nationwide US Commercial Insurance Claims Database. JAMA Netw Open. 2019 12 02; 2(12):e1917603.
Score: 0.161
-
Cost and Health Care Utilization Implications of Bariatric Surgery Versus Intensive Lifestyle and Medical Intervention for Type 2 Diabetes. Obesity (Silver Spring). 2017 09; 25(9):1499-1508.
Score: 0.136
-
Bariatric Surgery and Long-term Durability of Weight Loss. JAMA Surg. 2016 11 01; 151(11):1046-1055.
Score: 0.130
-
Improvements in glycemic control after gastric bypass occur despite persistent adipose tissue inflammation. Obesity (Silver Spring). 2016 07; 24(7):1438-45.
Score: 0.126
-
Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia. 2016 May; 59(5):945-53.
Score: 0.124
-
Comparing Medical Costs and Use After Laparoscopic Adjustable Gastric Banding and Roux-en-Y Gastric Bypass. JAMA Surg. 2015 Aug; 150(8):787-94.
Score: 0.119
-
Comparative effectiveness of bariatric surgery vs. nonsurgical treatment of type 2 diabetes among severely obese adults. Obes Res Clin Pract. 2013 Jul-Aug; 7(4):e258-68.
Score: 0.103
-
Decision modeling to estimate the impact of gastric bypass surgery on life expectancy for the treatment of morbid obesity. Arch Surg. 2010 Jan; 145(1):57-62.
Score: 0.081
-
Obesity. Clin Evid. 2005 Jun; (13):707-25.
Score: 0.059